Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Asset Utilization Ratio (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Asset Utilization Ratio for 3 consecutive years, with 0.01 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 53.56% to 0.01 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.01, a 53.56% decrease, with the full-year FY2023 number at 0.14, changed N/A from a year prior.
  • Asset Utilization Ratio was 0.01 for Q3 2025 at Mereo BioPharma, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.16 in Q1 2024 to a low of 0.0 in Q1 2025.
  • A 3-year average of 0.04 and a median of 0.01 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest YoY gain for Asset Utilization Ratio was 53.56% in 2025; the steepest drop was 101.52% in 2025.
  • Mereo BioPharma's Asset Utilization Ratio stood at 0.08 in 2023, then plummeted by 87.19% to 0.01 in 2024, then tumbled by 53.56% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Asset Utilization Ratio are 0.01 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025).